Epstein-Barr virus-associated peripheral T-Cell and NK-Cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis
β Scribed by Winyou Mitarnun; Supaporn Suwiwat; Jintana Pradutkanchana; Vannarat Saechan; Takafumi Ishida; Satomi Takao; Atsumi Mori
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 91 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Whether particular Epstein-Barr virus (EBV) strains are preferentially selected in malignant diseases remains controversial. Assessment of the importance of strain variation in the pathogenicity of EBV has been hampered principally by the lack of accurate data on the prevalence of virus variants in
A 74-year-old Japanese man presented with systemic lymphadenopathy, hepatosplenomegaly, and erythroderma in December 1991. A characteristic pattern of anti-EBV antibodies was suggestive of latent EBV infection. A skin tumor biopsied in April 1993 contained biclonal EBV genomes diffusely in the infil
## Epstein -Barr virus (EBV) post-transplantation B lymphoproliferative disease (BLPD) may undergo regression after immunosuppression withdrawal and restoration of EBV-specific cytotoxic T-cell (CTL) activity in the immunocompromised allografted host. The presence of morphologically normal T cells